Literature DB >> 2683681

Possible mechanisms underlying peripheral lymphocyte activation in chronic liver disease and asymptomatic HBsAg carriers.

M Raptopoulou-Gigi1, H Orphanou-Koumerkeridou, F Lagra.   

Abstract

Proportions of T lymphocyte subsets (OKT3, OKT4, OKT8) and expression of interleukin-2 (IL-2), transferrin (TFR) receptors and HLA-DR antigens were studied in the peripheral blood of 21 healthy HBsAg carriers, 10 patients with chronic active hepatitis B (CAH), 10 patients with alcoholic liver cirrhosis (ALC) and 10 subjects with negative markers of previous hepatitis B virus (HBV) infection. T lymphocyte subsets ranged within normal levels in CAH and carriers, whereas a significant decrease of OKT4 was noted in ALC possibly involved in the pathogenesis of this disorder. Significantly elevated numbers of activated cells (cells expressing IL-2, TFR receptors and HLA-DR antigens) were observed in all three groups. A significant increase in OKT8 cells within the TFR population was noted in CAH and ALC, whereas proportions of T subsets in the TFR population were normal in carriers. These findings possibly suggest a common pathogenetic mechanism in the activation of lymphocytes in CAH and ALC leading to liver damage and an immune response against HBV in healthy carriers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2683681

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  2 in total

1.  Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.

Authors:  John Idoko; Seema Meloni; Mohammed Muazu; Ladep Nimzing; Bitrus Badung; Claudia Hawkins; Jean-Louis Sankalé; Ernest Ekong; Robert Murphy; Phyllis Kanki; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

2.  Seroprevalence of hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria.

Authors:  Olatunji M Kolawole; Abideen A Wahab; Daniel A Adekanle; Timothy Sibanda; Anthony I Okoh
Journal:  Virol J       Date:  2012-12-27       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.